Nicholas Beyda
Cited by
Cited by
FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
ND Beyda, J John, A Kilic, MJ Alam, TM Lasco, KW Garey
Clinical infectious diseases 59 (6), 819-825, 2014
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches
ND Beyda, RE Lewis, KW Garey
Annals of Pharmacotherapy 46 (7-8), 1086-1096, 2012
Antifungal resistance: a concerning trend for the present and future
JA Hendrickson, C Hu, SL Aitken, N Beyda
Current infectious disease reports 21 (12), 1-8, 2019
Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy
AK Sofjan, A Mitchell, DN Shah, T Nguyen, M Sim, A Trojcak, ND Beyda, ...
Journal of global antimicrobial resistance 14, 58-64, 2018
Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples
ND Beyda, MJ Alam, KW Garey
Diagnostic microbiology and infectious disease 77 (4), 324-326, 2013
Treatment of Candida famata bloodstream infections: case series and review of the literature
ND Beyda, SH Chuang, MJ Alam, DN Shah, TM Ng, L McCaskey, ...
Journal of Antimicrobial Chemotherapy 68 (2), 438-443, 2013
Clinical Practice Patterns in Hospitalized Patients at Risk for Invasive Candidiasis Role of Antifungal Stewardship Programs in an Era of Rapid Diagnostics
SL Aitken, ND Beyda, DN Shah, HR Palmer, TM Lasco, H Koo, KW Garey
Annals of Pharmacotherapy 48 (6), 683-690, 2014
Early Administration of Adjuvant β‐Lactam Therapy in Combination with Vancomycin among Patients with Methicillin‐Resistant Staphylococcus aureus Bloodstream Infection: A …
AM Casapao, DM Jacobs, DR Bowers, ND Beyda, TJ Dilworth, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (11 …, 2017
Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris
S Wurster, A Bandi, ND Beyda, ND Albert, NM Raman, II Raad, ...
Journal of Antimicrobial Chemotherapy 74 (7), 1904-1910, 2019
Overtreatment of asymptomatic candiduria among hospitalized patients: a multi-institutional study
DM Jacobs, TJ Dilworth, ND Beyda, AM Casapao, DR Bowers
Antimicrobial agents and chemotherapy 62 (1), e01464-17, 2018
Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy
CGM Jardin, HR Palmer, DN Shah, F Le, ND Beyda, Z Jiang, KW Garey
Journal of Hospital Infection 85 (1), 28-32, 2013
In vitro evaluation of BacT/Alert FA blood culture bottles and T2Candida assay for detection of Candida in the presence of antifungals
ND Beyda, J Amadio, JR Rodriguez, K Malinowski, KW Garey, A Wanger, ...
Journal of clinical microbiology 56 (8), e00471-18, 2018
Innate Inflammatory Response and Immunopharmacologic Activity of Micafungin, Caspofungin, and Voriconazole against Wild-Type and FKS Mutant Candida glabrata Isolates
ND Beyda, G Liao, BT Endres, RE Lewis, KW Garey
Antimicrobial agents and chemotherapy 59 (9), 5405-5412, 2015
Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA
AK Sofjan, RJ Musgrove, ND Beyda, HP Russo, TM Lasco, R Yau, ...
Journal of global antimicrobial resistance 15, 41-47, 2018
Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: Does β-Lactam Class Matter?
TJ Dilworth, AM Casapao, OM Ibrahim, DM Jacobs, DR Bowers, ...
Antimicrobial agents and chemotherapy 63 (3), e02211-18, 2019
Significant publications on infectious diseases pharmacotherapy in 2011
TT Tran, ND Beyda, LR Biehle, JM Cottreau, K Echevarria, WL Musick, ...
American Journal of Health-System Pharmacy 69 (19), 1671-1681, 2012
Echinocandin use in hospitalized patients: a multi-institutional study
KW Garey, SL Aitken, A Dima-Ala, ND Beyda, K Kuper, Y Xie, HL Koo
The American journal of the medical sciences 349 (4), 316-320, 2015
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and …
RE Lewis, S Wurster, ND Beyda, ND Albert, DP Kontoyiannis
Diagnostic Microbiology and Infectious Disease 95 (3), 114861, 2019
Host factors and clinical outcomes of Candida colonization in critically ill patients
DM Jacobs, ND Beyda, O Asuphon, M Jahangir Alam, KW Garey
Mycopathologia 179 (1), 87-93, 2015
Immunomodulatory Agents as Adjunctive Therapy for the Treatment of Resistant Candida Species
ND Beyda, S Regen, RE Lewis, KW Garey
Current Fungal Infection Reports 7 (2), 119-125, 2013
The system can't perform the operation now. Try again later.
Articles 1–20